Participants were randomized to receive treatment with 17 - estradiol 2mg/day ; 17 - estradiol 2mg/day and terbutaline 5mg/day ( selective B2AR agonist ) ; propranolol 80mg/day ( non-selective B-AR antagonist ) ; or no treatment during 12weeks .